ABNORMAL EXPRESSION OF MOLECULAR MARKERS FOR BLADDER IMPERMEABILITY AND DIFFERENTIATION IN THE UROTHELIUM OF PATIENTS WITH INTERSTITIAL CYSTITIS-Reference-Cited by-同舟云学术

ABNORMAL EXPRESSION OF MOLECULAR MARKERS FOR BLADDER IMPERMEABILITY AND DIFFERENTIATION IN THE UROTHELIUM OF PATIENTS WITH INTERSTITIAL CYSTITIS

Published:2004-04 Issue:4 Volume:171 Page:1554-1558
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SLOBODOV GENNADY¹,FELONEY MICHAEL¹,GRAN CHRISTOPHER¹,KYKER KIMBERLY D.¹,HURST ROBERT E.¹,CULKIN DANIEL J.¹

Affiliation:

1. From the Department of Urology, Oklahoma University Health Sciences Center (GS, MF, CG, KDK, REH, DJC), Departments of Biochemistry and Molecular Biology and Physiology, College of Medicine (REH) and Department of Occupational and Environmental Health, College of Public Health (REH), Oklahoma City, Oklahoma

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. The epidemiology of interstitial cystitis: is it time to expand our definition?;Kusek;Urology,2001

2. Epidemiology of interstitial cystitis;Jones;Urology,1997

3. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987;Gillenwater;J Urol,1988

4. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics;Simon;Urology,1997

5. The role of glycosaminoglycans in normal bladder physiology and the pathophysiology of interstitial cystitis;Hurst,1997

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cdk1/p53/p21 feedback loop mechanisms in the pathogenesis of interstitial cystitis/bladder pain syndrome;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. Current clinical status of IC/BPS and what the future holds in basic & translational science;Continence;2024-09

3. Interconnected microbiomes—insights and innovations in female urogenital health;The FEBS Journal;2024-07-30

4. Efficacy and predictive factors of clinical response to hyaluronic acid ＋ chondroitin sulfate bladder instillations for the treatment of BPS/IC;Continence;2024-06

5. The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models;Current Opinion in Urology;2023-11-21